Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern 3 Vct Regulatory News (NTN)

Share Price Information for Northern 3 Vct (NTN)

Share Price is delayed by 15 minutes
Get Live Data
81.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (3.774%)
Market Cap: £144.04m
NTN Live PriceLast checked at - London Stock Exchange

Intraday Northern 3 Vct Share Chart

Interim Management Statement

31 Jul 2008 12:00

RNS Number : 3327A
Northern 3 VCT PLC
31 July 2008
 

31 JULY 2008

NORTHERN 3 VCT PLC

INTERIM MANAGEMENT STATEMENT

FOR THE QUARTER ENDED 30 JUNE 2008

Northern 3 VCT PLC presents its interim management statement for the quarter ended 30 June 2008. This constitutes the company's first interim management statement for the financial year ending 31 March 2009, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement has been prepared solely to provide additional information in order to meet the requirements of the Disclosure and Transparency Rules and should not be relied on by shareholders, or any other party, for any other purpose.

The unaudited net asset value per ordinary share as at 30 June 2008 was 94.0p (31 March 2008 96.3p).

The number of ordinary shares in issue at 30 June 2008 was 29,228,263. During the quarter ended 30 June 2008 no new shares were issued and a total of 520,825 shares were re-purchased by the company for cancellation at an average price of 86.7p per share.

Quoted investments are carried at bid price as at 30 June 2008. Unquoted investments are carried at fair value as at 30 June 2008 as determined by the directors.

During the three months ended 30 June 2008 the following significant investment transactions took place (all companies unquoted except where otherwise indicated):

New investments:

Name of company

Business activity

Amount invested £000

IS Pharma (AIM-quoted)

Supplier of specialist hospital medicines

78

Disposals:

Name of company

Sales proceeds £000

Original cost £000

Carrying value at 31 March 2008 £000

Product Support (Holdings)

1,988

1,000

1,547

Product Support (Holdings) was acquired by Wincanton plc for cash in May 2008.

The Government announced in the 2008 Budget that, with effect from 1 October 2008, investment management fees paid by VCTs would be exempt from VAT. HM Revenue & Customs has subsequently accepted that under European Union VAT law this exemption should have applied from 1 January 1990 onwards, and has indicated that claims may be made for repayment of VAT previously paid by VCTs on management fees, subject to certain restrictive time limits.

Pending clarification of the basis and timing of dealing with VAT repayment claims relating to past periods, no benefit has yet been recognised in the company's accounts in respect of the potential recovery. The directors consider that the effect on net asset value per share is unlikely to be material. An update will be given in the company's half-yearly report for the six months ending 30 September 2008, which is expected to be published in November 2008.

The directors are not aware of any other events or transactions which have taken place between 31 March 2008 and the date of publication of this statement and which have had a material effect on the financial position of the company.

Enquiries:

Alastair Conn/Christopher Mellor, NVM Private Equity Limited - 0191 244 6000

Website: www.nvm.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBGGDRIUXGGIB
Date   Source Headline
17th Jun 20254:30 pmGNWStatement regarding intention to fundraise
17th Jun 20254:30 pmGNWDividend Declaration
30th May 20257:00 amGNWTotal voting rights
30th Apr 202511:00 amGNWTotal voting rights
25th Apr 20257:00 amGNWNon-Executive Director Appointment
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202510:00 amGNWIssue of Equity and Total Voting Rights
31st Mar 202511:00 amGNWTotal voting rights
24th Mar 20254:30 pmGNWTransaction in Own Shares
28th Feb 202511:00 amGNWTotal voting rights
25th Feb 20259:00 amGNWOffer for subscription update
6th Feb 20258:00 amGNWNet Asset Value
31st Jan 202511:00 amGNWTotal voting rights
22nd Jan 20258:00 amGNWIssue of Equity and Total Voting Rights
17th Jan 20254:15 pmGNWTransaction in Own Shares
14th Jan 20258:00 amGNWOffer for subscription
9th Jan 20252:00 pmGNWPublication of Prospectus
31st Dec 202411:00 amGNWTotal voting rights
4th Dec 20248:00 amGNWTransaction in Own Shares
29th Nov 202411:00 amGNWTotal voting rights
21st Nov 20243:00 pmGNWHalf-yearly report
21st Nov 20242:01 pmGNWDividend Declaration
21st Nov 20242:00 pmGNWUnaudited Half-Yearly Financial Report for the Six Months Ended 30 September 2024
31st Oct 202411:00 amGNWTotal voting rights
30th Sep 202411:00 amGNWTotal voting rights
26th Sep 20248:00 amGNWTransaction in Own Shares
23rd Sep 202410:00 amGNWStatement regarding intention to fundraise
30th Aug 202411:00 amGNWTotal voting rights
23rd Aug 20248:00 amGNWIssue of Equity and Total Voting Rights
12th Aug 20243:30 pmGNWTransaction in Own Shares
2nd Aug 20248:00 amGNWNet Asset Value
1st Aug 20244:00 pmGNWResult of AGM
31st Jul 202411:00 amGNWTotal voting rights
5th Jul 20248:00 amGNWTransaction in Own Shares
28th Jun 20243:00 pmGNWAnnual Report and Notice of AGM
28th Jun 202411:00 amGNWTotal voting rights
18th Jun 20243:01 pmGNWDividend Declaration
18th Jun 20243:00 pmGNWANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024
31st May 202411:00 amGNWTotal voting rights
30th Apr 202411:00 amGNWTotal voting rights
4th Apr 20248:00 amGNWIssue of Equity and Total Voting Rights
28th Mar 202411:00 amGNWTotal voting rights
21st Mar 20243:00 pmGNWTransaction in Own Shares
12th Mar 20242:00 pmGNWOffer Update
6th Mar 20244:30 pmGNWTransaction in Own Shares
29th Feb 202411:00 amGNWTotal voting rights
9th Feb 20248:00 amGNWNet Asset Value
31st Jan 202411:00 amGNWTotal voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.